Aisys and Avance Anesthesia System Recall: Control Board Defect
A Class 1 medical device recall has been issued for GE Healthcare Aisys and Avance Anesthesia Systems, which can fail to provide ventilation for patients under the affects of anesthetics.
The anesthesia system recall was announced by FDA on May 10 and given a class 1 status after GE Healthcare officials sent an “Urgent Medical Device Correction” letter in March to the management at hospitals which had bought the machines. The FDA reports that the recalled machines have a defective control board wiring harness, which can cause the machine to shut down unexpectedly, resulting in loss of ventilation for the patient, anesthetic delivery and patient monitoring.
The FDA did not say whether there had been any injuries or deaths associated with the recall. A Class 1 designation is the most severe classification for a medical device recall, and means that the FDA believes that there is a reasonable probability that using the defective product could result in serious injury or death.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The affected machines include 18 Avance Anesthesia Machine and Monitor systems, product number 1009-9002-000. Four of the machines were sold in the U.S. and 14 were sold to other countries. The recall also includes 15 Aisys Anesthesia Machine and Monitor systems, product number 1011-90000-000, all sold outside the U.S.
The serial numbers of every machine affected are listed on FDA’s recall notice.
The FDA requests that anyone who experienced adverse events while using these products or under the effects of one of these products contact the FDA’s MedWatch Program at www.fda.gov/medwatch.
"*" indicates required fields
More Top Stories
A ProPublica report reveals that Philips officials hid thousands of reports of problems with sound abatement foam used in millions of CPAP machines, failing to recall the devices for more than a decade after receiving the first complaints.
A Suboxone lawsuit claims the opioid addiction treatment's dental side effects can lead to severe tooth damage and decay.
The FDA is requiring new label warnings to alert patients and doctors to the risk of Ozempic intestinal blockage side effects.